Clinical Trial Update: REPlaCE- Randomized Trial Evaluating the Use of Prothrombin Complex concEntrate to Improve Survival in Patients With Traumatic Coagulopathy [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial (REPlaCE) evaluating prothrombin complex concentrate to improve survival in patients with traumatic coagulopathy and hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage
• Traumatic Coagulopathy

Drugs mentioned

• Prothrombin Complex Concentrate (prothrombin complex concentrate)

Snippet

Sponsor: Bellal A. Joseph, MD, FACS | Conditions: Coagulopathy, Hemorrhage | Phase 2 | Status: UNKNOWN